Join
BlackRock Technology and Private Equity Term Trust logo

BTX

AMEX

BlackRock Technology and Private Equity Term Trust

IPO2021
$8.68-0.09 (-1.03%)
News25/Ratings2

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company is based in Brooklyn, New York.

Price$8.68-0.16 (-1.81%)
01:30 PM07:45 PM
News · 26 weeks16+50%
2025-12-14: 02025-12-21: 12025-12-28: 22026-01-04: 02026-01-11: 02026-01-18: 02026-01-25: 12026-02-01: 22026-02-08: 02026-02-15: 02026-02-22: 22026-03-01: 12026-03-08: 12026-03-15: 02026-03-22: 02026-03-29: 12026-04-05: 02026-04-12: 02026-04-19: 02026-04-26: 12026-05-03: 02026-05-10: 12026-05-17: 02026-05-24: 12026-05-31: 22026-06-07: 0
2025-12-142026-06-07
Mix790d
  • Dividends4(57%)
  • Other2(29%)
  • SEC Filings1(14%)

Latest news

25 items

BTX FAQ

6 questions
  • What does BlackRock Technology and Private Equity Term Trust do?
    Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company is based in Brooklyn, New York.
  • Where does BTX stock trade?
    BlackRock Technology and Private Equity Term Trust (BTX) is listed on AMEX.
  • When did BlackRock Technology and Private Equity Term Trust go public?
    BlackRock Technology and Private Equity Term Trust (BTX) completed its IPO in 2021.
  • Does BTX pay a dividend?
    Yes. BTX's next ex-dividend date is 2026-06-15 with a declared cash dividend of $0.05 per share, payable 2026-06-30.
  • What are analysts saying about BTX?
    BlackRock Technology and Private Equity Term Trust has had 2 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight with a $900.00 price target on 2021-12-29. Recent price targets range from $900.00 to $2000.00.
  • How can I track BTX on Quantisnow?
    Quantisnow aggregates BlackRock Technology and Private Equity Term Trust's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BTX to receive live email and push alerts on every new disclosure.